Floatz logo

Therapeutic Asset Ratings

7,018 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
FILGRASTIM
Nodular Sclerosis Classical Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (69)
FILGRASTIM
Chemotherapy-induced Neutropenia
Ankara Etlik City HospitalP3BB (69)
FILGRASTIM
Hodgkin'S Lymphoma, Lymphocytic Depletion
National Cancer Institute (NCI)P3BB (69)
FILGRASTIM
Childhood Mixed Cellularity Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (69)
FILGRASTIM
Childhood Nodular Sclerosis Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (69)
FILGRASTIM
Myeloproliferative Neoplasm
City of Hope Medical CenterP3BB (69)
FILGRASTIM
HIV Infectious Disease
Fred Hutchinson Cancer CenterP3BB (69)
FILGRASTIM
Myelodysplastic Syndrome With Excess Blasts
M.D. Anderson Cancer CenterP3BB (69)
Fludarabine
Disease Related To Hematopoietic Stem Cell Transplant
First Affiliated Hospital of Zhejiang UniversityP3BB (69)
Fludarabine
Plasma Cell Neoplasm
Affiliated Hospital to Academy of Military Medical SciencesP3BB (69)
Fludarabine
Prolymphocytic Leukemia
Center for International Blood and Marrow Transplant ResearchP3BB (69)
Fludarabine
Lymphoblastic Lymphoma
Ohio State University Comprehensive Cancer CenterP3BB (69)
Fludarabine
Disease Related To Transplantation
M.D. Anderson Cancer CenterP3BB (69)
Fludarabine
Untreated Adult Acute Myeloid Leukemia
City of Hope Medical CenterP3BB (69)
FLUDEOXYGLUCOSE
Non-Small Cell Lung Carcinoma
Alliance for Clinical Trials in OncologyP3BB (69)
FLUDROCORTISONE
Congenital Adrenal Hyperplasia
University of Texas Southwestern Medical CenterP3BB (69)
FLUOROURACILUM
Liver Metastasis Colon Cancer
Jun HuangP3BB (69)
FLUOROURACILUM
Peritoneum Cancer
City of Hope Medical CenterP3BB (69)
Gilteritinib
Acute Myeloid Leukemia, FLT3 Internal Tandem Duplication
The First Affiliated Hospital of Soochow UniversityP3BB (69)
Hetrombopag
Thrombocytopenia
Sun Yat-sen UniversityP3BB (69)
HR20013
Chemotherapy-Induced Toxicity
Fujian Shengdi Pharmaceutical Co., Ltd.P3BB (69)
Imatinib
B-Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34.1;Q11.2)
The University of Hong KongP3BB (69)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Colon Carcinoma
IFOM ETS - The AIRC Institute of Molecular OncologyP3BB (69)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Recurrent Colon Carcinoma
IFOM ETS - The AIRC Institute of Molecular OncologyP3BB (69)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Lymphoplasmacytic Lymphoma
Memorial Sloan Kettering Cancer CenterP3BB (69)
Showing 701 to 725 of 7,018 assets
PreviousPage 29 of 281Next